Childhood bacterial respiratory diseases: past, present, and future

Hanna Nohynek1, Shabir Madhi, Carlos G Grijalva

  • 1National Institute for Health and Welfare, Helsinki, Finland. hanna.nohynek@thl.fi

Insights

Pneumonia remains a global child survival challenge, despite vaccines for common infections. Further research and interventions, especially vaccines, are critical to reduce childhood pneumonia mortality.

Area of Science:

  • Global Health
  • Pediatrics
  • Infectious Diseases

Background:

  • Pneumonia is a leading cause of acute respiratory infection and a significant threat to child survival worldwide.
  • While vaccines have reduced some major infectious diseases, bacterial pneumonia, including severe cases, persists as a public health issue globally.
  • Childhood mortality and morbidity from pneumonia are influenced by various risk factors.

Purpose of the Study:

  • To examine the causes of global childhood mortality.
  • To analyze the distribution of childhood pneumonia mortality and morbidity.
  • To review available vaccines and their effectiveness in reducing childhood bacterial respiratory diseases.

Main Methods:

  • Review of published literature on vaccines for bacterial respiratory diseases.
  • Analysis of global childhood mortality data.
  • Examination of risk factors for pneumonia incidence.

Main Results:

  • Vaccination has reduced incidence of major bacterial and viral respiratory infections like Hib and pneumococcal disease.
  • Bacterial pneumonia, particularly severe forms requiring hospitalization, continues to be a challenge in both low-resource and high-income countries.
  • Vaccines are critical interventions for reducing childhood mortality, offering rapid, feasible, and sustained impact.

Conclusions:

  • Further epidemiologic studies are needed to identify the full disease burden of pneumonia.
  • Urgent implementation of proven, cost-effective interventions, especially vaccines, is necessary to reduce childhood mortality.
  • Vaccines play a critical role in public health strategies aimed at achieving Millennium Development Goals for child survival.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...